Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Universitätsklinikum Gießen und Marburg (UKGM) is the third-largest university hospital in Germany, formed by the merger of the university clinics of Gießen and Marburg in 2005. It is notable for being the first privatized university hospital in Germany, currently operating as a subsidiary of Rhön-Klinikum AG under the Asklepios Kliniken umbrella. The hospital provides a comprehensive range of medical services, from primary care to highly specialized supra-maximal treatments across two main campuses. UKGM is a major hub for clinical research and medical education, maintaining close ties with the Justus Liebig University Gießen and the Philipps University Marburg. Its research activities are particularly strong in fields such as oncology, cardiovascular medicine, and pulmonology, often serving as a key site for international clinical trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Universitätsklinikum Gießen und Marburg.